413 related articles for article (PubMed ID: 30826188)
1. Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Ali EMH; Abdel-Maksoud MS; Oh CH
Bioorg Med Chem; 2019 Apr; 27(7):1159-1194. PubMed ID: 30826188
[TBL] [Abstract][Full Text] [Related]
2. Bridgehead Nitrogen Thiazolo[3,2-a]pyrimidine: A Privileged Structural Framework in Drug Discovery.
Keshari AK; Singh AK; Saha S
Mini Rev Med Chem; 2017; 17(15):1488-1499. PubMed ID: 28215139
[TBL] [Abstract][Full Text] [Related]
3. An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold.
Cherukupalli S; Hampannavar GA; Chinnam S; Chandrasekaran B; Sayyad N; Kayamba F; Reddy Aleti R; Karpoormath R
Bioorg Med Chem; 2018 Jan; 26(2):309-339. PubMed ID: 29273417
[TBL] [Abstract][Full Text] [Related]
4. Thiazolo[4,5-d]pyrimidines as a privileged scaffold in drug discovery.
Kuppast B; Fahmy H
Eur J Med Chem; 2016 May; 113():198-213. PubMed ID: 26942627
[TBL] [Abstract][Full Text] [Related]
5. An overview on synthetic and pharmaceutical prospective of pyrido[2,3-d]pyrimidines scaffold.
Yadav P; Shah K
Chem Biol Drug Des; 2021 Mar; 97(3):633-648. PubMed ID: 32946161
[TBL] [Abstract][Full Text] [Related]
6. New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds.
Abdellatif KRA; Bakr RB
Bioorg Chem; 2018 Aug; 78():341-357. PubMed ID: 29627655
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential, Synthesis, Patent Evaluation and SAR Studies of Thieno[3,2-d]pyrimidine Derivatives: Recent Updates.
Islam F; Quadery TM
Curr Drug Targets; 2021; 22(17):1944-1963. PubMed ID: 34042033
[TBL] [Abstract][Full Text] [Related]
8. Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities.
Ghith A; Ismail NSM; Youssef K; Abouzid KAM
Arch Pharm (Weinheim); 2017 Nov; 350(11):. PubMed ID: 29027246
[TBL] [Abstract][Full Text] [Related]
9. Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents.
Lagardère P; Fersing C; Masurier N; Lisowski V
Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056092
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic advancement of benzothiazole derivatives in the last decennial period.
Tariq S; Kamboj P; Amir M
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800170. PubMed ID: 30488989
[TBL] [Abstract][Full Text] [Related]
11. 1,3-Thiazole Derivatives as a Promising Scaffold in Medicinal Chemistry: A Recent Overview.
Kushwaha P; Pandey S
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(3):133-163. PubMed ID: 37997807
[TBL] [Abstract][Full Text] [Related]
12. Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect.
Zhao Z; Dai X; Li C; Wang X; Tian J; Feng Y; Xie J; Ma C; Nie Z; Fan P; Qian M; He X; Wu S; Zhang Y; Zheng X
Eur J Med Chem; 2020 Jan; 186():111893. PubMed ID: 31761383
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the chemistry and biology of pyridopyrimidines.
Buron F; Mérour JY; Akssira M; Guillaumet G; Routier S
Eur J Med Chem; 2015 May; 95():76-95. PubMed ID: 25794791
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimicrobial activity of new substituted thienopyrimidines, their tetrazolyl and sugar derivatives.
El-Sayed WA; Ali OM; Zyada RA; Mohamed AA; Abdel-Rahman AA
Acta Pol Pharm; 2012; 69(3):439-47. PubMed ID: 22594258
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of 3-pyrazolyl-thiophene, thieno[2,3-d]pyrimidines as new bioactive and pharmacological activities.
Hafez HN; El-Gazzar AB
Bioorg Med Chem Lett; 2008 Oct; 18(19):5222-7. PubMed ID: 18783947
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity study leading to identification of a highly active thienopyrimidine based EGFR inhibitor.
Bugge S; Kaspersen SJ; Larsen S; Nonstad U; Bjørkøy G; Sundby E; Hoff BH
Eur J Med Chem; 2014 Mar; 75():354-74. PubMed ID: 24556149
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
18. Recent Applications of Triazolopyrimidine-Based Bioactive Compounds in Medicinal and Agrochemical Chemistry.
Renyu Q; Yuchao L; Kandegama WMWW; Qiong C; Guangfu Y
Mini Rev Med Chem; 2018; 18(9):781-793. PubMed ID: 29090667
[TBL] [Abstract][Full Text] [Related]
19. Triazolopyrimidine Derivatives: An Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Aspects.
Abdelkhalek AS; Attia MS; Kamal MA
Curr Med Chem; 2024; 31(14):1896-1919. PubMed ID: 36852819
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the synthetic and medicinal perspective of quinolones: A review.
Dhiman P; Arora N; Thanikachalam PV; Monga V
Bioorg Chem; 2019 Nov; 92():103291. PubMed ID: 31561107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
